Pharmacokinetic Infliximab Data in Pediatric Crohn's Disease
NCT05552287
·
clinicaltrials.gov ↗
PHASE4
Phase
RECRUITING
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Crohn Disease
Child, Only
Biologic; Inadequate
Interventions
DRUG:
Infliximab
Sponsor
Erasmus Medical Center